Nasdaq
$0.4404▼ 2.13%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $20.6MShares out 46.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
7- 9.23After-hours26.09.24 05:054Ownership#●●●#●●●
InspireMD, Inc.
InspireMD entered into amendments for its Series J and Series K warrants with the Reporting Person on September 18, 2026. The amendments modified the exercise price and termination date for 30,625 shares of the Series J warrant and all shares of the Series K warrant, setting the new termination date to the earlier of May 15, 2028, or 20 trading days following the FDA approval of the CGuard Prime 80cm.…more
$0.4404-2.13%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.23After-hours26.09.24 05:054Ownership
InspireMD, Inc.
InspireMD entered into amendments to its Series J and Series K warrants with the reporting person on September 18, 2026. These amendments modified the exercise price and termination date for 15,313 shares of the Series J warrant and all shares of the Series K warrant, aligning the expiration to the earlier of May 15, 2028, or 20 trading days following the FDA approval of the CGuard Prime 80cm.…more
$0.4404-2.13%vs prev closeView filingShare - 9.23After-hours26.09.24 05:054Ownership
InspireMD, Inc.
InspireMD entered into agreements on September 18, 2026, to amend the exercise price and termination dates of existing Series J and Series K warrants. The amendments adjust the termination conditions for 43,750 shares of the Series J warrant and all shares of the Series K warrant to the earlier of May 15, 2028, or 20 trading days following the company's announcement of FDA approval for the CGuard Prime 80cm.…more
$0.4404-2.13%vs prev closeView filingShare
6 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.21Pre-market26.09.21 22:00Bullish#●●●#●●●#●●●
InspireMD Amends Warrants to Secure Up to $11 Million in Potential Proceeds…more
InspireMD is modifying existing warrant terms to align with anticipated FDA approval, aiming to raise up to $11 million for product commercialization. While this provides necessary capital for the CGuard Prime launch, the potential exercise of these warrants may lead to shareholder dilution.…more
$0.4404-2.13%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.4After-hours26.09.05 05:01
●●●●●●●● ●●●●● ●●●●●●
InspireMD has granted 23,764 shares of restricted stock to a new employee as an inducement for employment under Nasdaq Listing Rule 5635(c)(4). This is a standard compensation practice for talent acquisition and does not impact the company's financial performance.…more
$0.4404-2.13%vs prev close - 8.10After-hours26.08.11 05:01
●●●●●●●● ●●●●● ●●●●●●
InspireMD will release its financial results for the second quarter of 2026 on August 17. The company will also host a conference call to discuss its recent highlights and financial performance.…more
$0.4404-2.13%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report